ABPP using chemical proteomics in Alzheimer's Disease and Resilience
Ontology highlight
ABSTRACT: pulldown on enzymes targeted by serine hydrolase probes tetrahydrolipstatin-biotin and fluorophosphonate biotin probe in lysates from the frontal cortex of 36 patients (12 conrol, 12 Alzheimer's, 12 Resilient). below is the abstract: Alzheimer’s Disease (AD) is the most common form of dementia. While it has become clear that alterations in lipid metabolism are associated with AD, it is not well understood how they contribute to both cognitive decline and the pathophysiology of AD. To better understand these changes, we performed lipidomics and activity-based proteomic profiling (ABPP) in the frontal cortex of a cohort of control, AD and resilient donors, the latter referring to individuals with AD pathology without declined cognition. We demonstrate that most changes in the lipidome are related to AD pathology. The class of lipids most strongly changed was ω6-derived oxylipins, which reflect a neuroinflammatory response. This lipid class was particularly increased in the AD patients compared to controls, while it showed a similar but non-significant trend in resilient donors. In contrast, both triacylglycerides (TAGs) and lipid droplets were more abundant in the AD donors compared to the resilient donors, but not to the control donors, indicating alterations in neutral lipids in resilient donors. Enzyme activities profiled by ABPP showed a similar direction in the AD and resilient donors, including decreased activity of ABHD6, a lipase involved in mono-acyl glycerol metabolism. Finally, using multi-omics factor analysis, we show that increased oxylipins, loss of inhibitory cells and reduced synaptic plasticity are associated with Aβ plaque load. This response was present in both the AD and resilient donors. Taken together, our multi-omics data show a response associated with Aβ load shared among AD and resilient donors and, for the first time, reduced lipid droplets in resilient donors.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Brain
DISEASE(S): Alzheimer's Disease 1
SUBMITTER:
Daan Van der Vliet
LAB HEAD: Prof. dr. Mario van der Stelt
PROVIDER: PXD057993 | Pride | 2026-02-09
REPOSITORIES: Pride
ACCESS DATA